Restoring ornithine transcarbamylase (OTC) activity in an OTC‐deficient mouse model using LUNAR‐OTC mRNA

• Main Authors: Hailong Yu (Author), Edward Brewer (Author), Michael Shields (Author), Michael Crowder (Author), Cristiano Sacchetti (Author), Benchawanna Soontornniyomkij (Author), Dandan Dou (Author), Brenda Clemente (Author), Marciano Sablad (Author), Padmanabh Chivukula (Author), Steve Hughes (Author), Scott Roberts (Author), Kumar Rajappan (Author), Steve Tannis (Author), Rose Sekulovich (Author), Suezanne Parker (Author), Pattraranee Limphong (Author)
• Format: Book
• Published: Wiley, 2022-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Ornithine transcarbamylase (OTC) catalyses the reaction from ornithine to citrulline in the urea cycle. Ornithine transcarbamylase deficiency (OTCD) results in episodes of hyperammonemia. Arcturus Therapeutics developed a lipid nanoparticle (LNP)‐encapsulated OTC‐mRNA (LUNAR‐OTC) that resul...